Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER networkLoreta A. Kondili, Stefano Vella, Giovanni Battista Gaeta et al.|PLoS ONE|2017Cited by 114
Multiclass <scp>HCV</scp> resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapiesVelia Chiara Di Maio, Francesca Ceccherini‐Silberstein, Valeria Cento et al.|Liver International|2017Cited by 90
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1–4 in ItalyAda Bertoli, Alessia Ciancio, Stefania Paolucci et al.|Scientific Reports|2018Cited by 48
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levelsVelia Chiara Di Maio, Valeria Cento, M. Aragri et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 13
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcomeValeria Cento, Francesca Ceccherini‐Silberstein, Daniele Di Paolo et al.|Digestive and Liver Disease|2014Cited by 5